Table 3.

Effect of functional drinks on glucose and insulin levels of rats

	Studies	Treatments
		T 1	T 2	T 3
Glucose (mg/dL)	Trial-I	93.55 ± 6.01	92.44 ± 4.43	90.44 ± 4.79
	Trial-II	105.60 ± 6.61	103.32 ± 5.26	101.51 ± 4.58
	Trial-III	125.93 ± 5.47a	113.21 ± 7.25b	110.40 ± 5.85b
	Trial-IV	130.05 ± 8.75a	121.07 ± 7.32b	119.57 ± 6.60b
Insulin (μU/mL)	Trial-I	9.33 ± 0.51	9.15 ± 0.68	9.14 ± 0.71
	Trial-II	11.05 ± 0.09	10.59 ± 0.15	10.34 ± 0.65
	Trial-III	14.34 ± 0.41a	12.65 ± 0.57b	12.20 ± 0.49b
	Trial-IV	16.34 ± 0.59a	14.20 ± 0.74b	13.65 ± 0.67b

Values are expressed as means ± SD.

Means carrying same letter in a row do not differ significantly.

Means showing different lettering in a row differed significantly at P < 0.05.

Trial-I: Normal diet.

Trial-II: High cholesterol diet.

Trial-III: High sucrose diet.

Trial-IV: High cholesterol + high sucrose diet.

T₁: Control drink (without active ingredients).

T₂: Drink containing catechins.

T₃: Drink containing EGCG.